Gulsen Meral
Research Subjects
Gulsen Meral has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Elif Sibel Aslan
Biruni University
3 shared publications - Esma Gokcen Alper Acar
Epigenetic Coaching, London SW10 9EL, UK
2 shared publications - Neval Burkay
Epigenetic Coaching, London SW10 9EL, UK
2 shared publications - Ahmet Avcı
Department of Biostatistics, Cerrahpaşa Faculty of Medicine, Istanbul University, Istanbul 34098, Turkey
1 shared publication - Aytug Altundag
Department of Otorhinolaryngology, Biruni University, Merkezefendi, 75 Sk No:1-13 M.G., 34015 Istanbul, Turkey
1 shared publication - Bilge Özlüer Başer
Mimar Sinan Guzel Sanatlar Universitesi
1 shared publication
Latest Publications
- Open Access
- 9 October 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (20) , 3277
Vitamin A and D Status, Selected Genetic Variants, and Allergy-Related Phenotypes: An Exploratory Retrospective Study
Background/Objectives: Vitamins A and D are critical regulators of immune function, and genetic variation in their metabolic pathways may influence vitamin status and immune responses. This study investigated the combined nutrigenetic roles of vitamins A and D and their association with allergy-related phenotypes. Methods: In this retrospective study, 80 individuals were included (40 with allergy-related phenotypes and 40 controls). Genetic polymorphisms in CYP2R1, GC, VDR, and BCMO1 were analyzed. Serum vitamin A and 25(OH)D concentrations were compared between groups, and multivariable analyses were performed to assess the effects of age and sex. Genotype distributions were evaluated using chi-square tests, and co-occurring genetic patterns were explored using the Apriori algorithm (p < 0.05). Results: Both serum vitamin A and 25(OH)D concentrations were significantly lower in the allergy-related phenotypes. Genotype differences were observed for CYP2R1 rs2060793 and BCMO1 rs12934922; however, only CYP2R1 rs2060793 remained significant after FDR correction. Although residual confounding cannot be ruled out, exploratory association rule mining identified co-occurrence patterns involving GC, VDR, and CYP2R1 variants with vitamin D deficiency and BCMO1 variants with vitamin A deficiency. These findings should be considered preliminary and hypothesis-generating rather than evidence of established or causal genetic effects. Conclusions: These preliminary findings indicate potential associations between vitamin status, specific genetic variants, and allergy-related phenotypes. Because of the study’s retrospective design and limited sample size, these genetic observations should be regarded as hypothesis-generating and warrant validation in larger, prospectively characterized cohorts.
- 9 October 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (20) , 3277
Open AccessVitamin A and D Status, Selected Genetic Variants, and Allergy-Related Phenotypes: An Exploratory Retrospective Study
Background/Objectives: Vitamins A and D are critical regulators of immune function, and genetic variation in their metabolic pathways may influence vitamin status and immune responses. This study investigated the combined nutrigenetic roles of vitamins A and D and their association with allergy-related phenotypes. Methods: In this retrospective study, 80 individuals were included (40 with allergy-related phenotypes and 40 controls). Genetic polymorphisms in CYP2R1, GC, VDR, and BCMO1 were analyzed. Serum vitamin A and 25(OH)D concentrations were compared between groups, and multivariable analyses were performed to assess the effects of age and sex. Genotype distributions were evaluated using chi-square tests, and co-occurring genetic patterns were explored using the Apriori algorithm (p < 0.05). Results: Both serum vitamin A and 25(OH)D concentrations were significantly lower in the allergy-related phenotypes. Genotype differences were observed for CYP2R1 rs2060793 and BCMO1 rs12934922; however, only CYP2R1 rs2060793 remained significant after FDR correction. Although residual confounding cannot be ruled out, exploratory association rule mining identified co-occurrence patterns involving GC, VDR, and CYP2R1 variants with vitamin D deficiency and BCMO1 variants with vitamin A deficiency. These findings should be considered preliminary and hypothesis-generating rather than evidence of established or causal genetic effects. Conclusions: These preliminary findings indicate potential associations between vitamin status, specific genetic variants, and allergy-related phenotypes. Because of the study’s retrospective design and limited sample size, these genetic observations should be regarded as hypothesis-generating and warrant validation in larger, prospectively characterized cohorts.
- Open Access
- 17 April 2026
- Published by EUCHEMBIOJ Publishing Platform in Euchembioj Reviews
- p. e26005
The effects of green tea and curcumin on COMT and MAO pathways in nutrigenetics-based epigenetic approaches: Clinical benefits and the balanced management of psycho-oncological risks
The worldwide prevalence of all cancer types continues to rise. In this context, the psychological burden of cancer—particularly anxiety and depression—has emerged as a critical yet frequently overlooked component of comprehensive oncological care. In addition to clinical and psychosocial factors, growing evidence suggests that epigenetic mechanisms significantly influence both cancer biology and mental health, indicating that gene-environment interactions may affect psychological vulnerability in oncology contexts. Nutrigenetics-based epigenetic approaches enable personalized dietary and nutraceutical interventions based on individual genetic variability. Green tea catechins and curcumin are widely used bioactive compounds due to their epigenetic and anticancer potential. However, by altering the activity of catechol-O-methyltransferase (COMT) and monoamine oxidase (MAO), important enzymes that degrade dopamine, norepinephrine, and serotonin, these substances have an impact on monoaminergic neurotransmission. Functional polymorphisms in the COMT and MAO genes may lead to substantial interindividual differences in mood regulation, stress responsiveness, and anxiety susceptibility. This review addresses molecular, clinical, and psycho-oncological aspects of the effects of green tea and curcumin on COMT and MAO pathways within a nutrigenetics-based epigenetic nutrition framework. The findings emphasize that the potential clinical benefits of epigenetically active nutraceuticals should be evaluated through a genotype-guided, individualized, and balanced approach.
- 17 April 2026
- Published by EUCHEMBIOJ Publishing Platform in Euchembioj Reviews
- p. e26005
Open AccessThe effects of green tea and curcumin on COMT and MAO pathways in nutrigenetics-based epigenetic approaches: Clinical benefits and the balanced management of psycho-oncological risks
The worldwide prevalence of all cancer types continues to rise. In this context, the psychological burden of cancer—particularly anxiety and depression—has emerged as a critical yet frequently overlooked component of comprehensive oncological care. In addition to clinical and psychosocial factors, growing evidence suggests that epigenetic mechanisms significantly influence both cancer biology and mental health, indicating that gene-environment interactions may affect psychological vulnerability in oncology contexts. Nutrigenetics-based epigenetic approaches enable personalized dietary and nutraceutical interventions based on individual genetic variability. Green tea catechins and curcumin are widely used bioactive compounds due to their epigenetic and anticancer potential. However, by altering the activity of catechol-O-methyltransferase (COMT) and monoamine oxidase (MAO), important enzymes that degrade dopamine, norepinephrine, and serotonin, these substances have an impact on monoaminergic neurotransmission. Functional polymorphisms in the COMT and MAO genes may lead to substantial interindividual differences in mood regulation, stress responsiveness, and anxiety susceptibility. This review addresses molecular, clinical, and psycho-oncological aspects of the effects of green tea and curcumin on COMT and MAO pathways within a nutrigenetics-based epigenetic nutrition framework. The findings emphasize that the potential clinical benefits of epigenetically active nutraceuticals should be evaluated through a genotype-guided, individualized, and balanced approach.
- Open Access
- 15 December 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (24) , 2823
An Epigenetic Locus Associated with Loss of Smell in COVID-19
Background/Aim: Loss of smell, also known as anosmia, is a prevalent and often prolonged symptom following infection with SARS-CoV-2. While many patients regain olfactory function within weeks, a significant portion experience persistent anosmia lasting over a year post-infection. The underlying mechanisms responsible for this sensory deficit remain largely uncharacterized. Previous studies, including genome-wide association studies (GWAS), have identified genetic variants near the UGT2A1 and UGT2A2 genes that are linked to anosmia in COVID-19 patients. However, the role of epigenetic changes in the development and persistence of smell loss has not been well explored. In this study, we aimed to investigate epigenetic alterations in the form of DNA methylation in the UGT1A1 gene, which is a locus associated with olfactory dysfunction in COVID-19 patients. Methods: We analysed DNA methylation patterns in blood samples from two carefully matched cohorts of 20 COVID-19 patients each, which are differentiated by their olfactory function—those with normal smell (normosmia) and those suffering from smell loss (anosmia). The cohorts were matched for age and sex to minimize potential confounding factors. Results: Using quantitative analysis, we found significantly lower levels of DNA methylation in the UGT1A1 locus in the anosmia group compared to the normosmia group, with a 14% decrease in median methylation values in patients with smell loss (p < 0.0001). These findings highlight potential epigenomic alterations in the UGT1A1 gene that may contribute to the pathogenesis of anosmia following COVID-19 infection. Our results suggest that the methylation status at this locus could serve as a biomarker for olfactory dysfunction in affected individuals. Conclusion: This study is among the first to describe epigenetic changes associated with smell loss in COVID-19, providing a foundation for future research into targeted interventions and potential therapeutic strategies aimed at reversing persistent anosmia. Further investigations involving larger cohorts and additional loci may help elucidate the complex interaction between genetic, epigenetic, and environmental factors influencing long-term sensory impairment post-COVID-19.
- 15 December 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (24) , 2823
Open AccessAn Epigenetic Locus Associated with Loss of Smell in COVID-19
Background/Aim: Loss of smell, also known as anosmia, is a prevalent and often prolonged symptom following infection with SARS-CoV-2. While many patients regain olfactory function within weeks, a significant portion experience persistent anosmia lasting over a year post-infection. The underlying mechanisms responsible for this sensory deficit remain largely uncharacterized. Previous studies, including genome-wide association studies (GWAS), have identified genetic variants near the UGT2A1 and UGT2A2 genes that are linked to anosmia in COVID-19 patients. However, the role of epigenetic changes in the development and persistence of smell loss has not been well explored. In this study, we aimed to investigate epigenetic alterations in the form of DNA methylation in the UGT1A1 gene, which is a locus associated with olfactory dysfunction in COVID-19 patients. Methods: We analysed DNA methylation patterns in blood samples from two carefully matched cohorts of 20 COVID-19 patients each, which are differentiated by their olfactory function—those with normal smell (normosmia) and those suffering from smell loss (anosmia). The cohorts were matched for age and sex to minimize potential confounding factors. Results: Using quantitative analysis, we found significantly lower levels of DNA methylation in the UGT1A1 locus in the anosmia group compared to the normosmia group, with a 14% decrease in median methylation values in patients with smell loss (p < 0.0001). These findings highlight potential epigenomic alterations in the UGT1A1 gene that may contribute to the pathogenesis of anosmia following COVID-19 infection. Our results suggest that the methylation status at this locus could serve as a biomarker for olfactory dysfunction in affected individuals. Conclusion: This study is among the first to describe epigenetic changes associated with smell loss in COVID-19, providing a foundation for future research into targeted interventions and potential therapeutic strategies aimed at reversing persistent anosmia. Further investigations involving larger cohorts and additional loci may help elucidate the complex interaction between genetic, epigenetic, and environmental factors influencing long-term sensory impairment post-COVID-19.
- 6 April 2023
- Published by Turkish Academy of Sciences
- p. 397-426
Nutrigenetik-Epigenetik
After the completion of the human genome project in 2003, the use of Predictive, Preventive, Personalized, Participatory therapy has gained momentum in modern medicine and pharmacy, with the demonstration of genetic variations among humans. Genome studies show that a person is special and separates from other people like a fingerprint. Differences in these personal genetic characteristics determine the individual’s susceptibility to diseases, treatment response and behavioral differences. The importance of the environmental factors behind the genetic structure in determining the phenotype has been understood with the Human Genome Project, followed by the Hap Map Project, then ENCODE, and the latest epigenome project. In the journey of Nutrigenetics and Epigenetics, we frequently encounter the question of genotype-phenotype. Genotype is the genetic code of individuals. The phenotype is the external appearance of the person that is affected by the genotype and environmental conditions. When we look at the gene structure among individuals, although 99.99% is the same genomic structure, a 0.1% change in between, that is, SNP (the replacement of one base by another in the DNA sequence) causes these changes. It has been observed that these differences in phenotype arise from differences such as food, living conditions, lifestyle, socio-cultural, and interaction with the change of economic levels. This situation also causes different diseases, different microbiota, allergies and etc.
- 6 April 2023
- Published by Turkish Academy of Sciences
- p. 397-426
Nutrigenetik-Epigenetik
After the completion of the human genome project in 2003, the use of Predictive, Preventive, Personalized, Participatory therapy has gained momentum in modern medicine and pharmacy, with the demonstration of genetic variations among humans. Genome studies show that a person is special and separates from other people like a fingerprint. Differences in these personal genetic characteristics determine the individual’s susceptibility to diseases, treatment response and behavioral differences. The importance of the environmental factors behind the genetic structure in determining the phenotype has been understood with the Human Genome Project, followed by the Hap Map Project, then ENCODE, and the latest epigenome project. In the journey of Nutrigenetics and Epigenetics, we frequently encounter the question of genotype-phenotype. Genotype is the genetic code of individuals. The phenotype is the external appearance of the person that is affected by the genotype and environmental conditions. When we look at the gene structure among individuals, although 99.99% is the same genomic structure, a 0.1% change in between, that is, SNP (the replacement of one base by another in the DNA sequence) causes these changes. It has been observed that these differences in phenotype arise from differences such as food, living conditions, lifestyle, socio-cultural, and interaction with the change of economic levels. This situation also causes different diseases, different microbiota, allergies and etc.
- Open Access
- 27 August 2021
- Published by Oxford University Press (OUP) in Family Practice
- Vol. 38 (Supplement) , i16-i22
COVID-19 and the flu: data simulations and computational modelling to guide public health strategies
Pandemics threaten lives and economies. This article addresses the global threat of the anticipated overlap of COVID-19 with seasonal-influenza. Scientific evidence based on simulation methodology is presented to reveal the impact of a dual outbreak, with scenarios intended for propagation analysis. This article aims at researchers, clinicians of family medicine, general practice and policy-makers worldwide. The implications for the clinical practice of primary health care are discussed. Current research is an effort to explore new directions in epidemiology and health services delivery. Projections consisted of machine learning, dynamic modelling algorithms and whole simulations. Input data consisted of global indicators of infectious diseases. Four simulations were run for ‘20% versus 60% flu-vaccinated populations’ and ‘10 versus 20 personal contacts’. Outputs consisted of numerical values and mathematical graphs. Outputs consisted of numbers for ‘never infected’, ‘vaccinated’, ‘infected/recovered’, ‘symptomatic/asymptomatic’ and ‘deceased’ individuals. Peaks, percentages, R0, durations are reported. The best-case scenario was one with a higher flu-vaccination rate and fewer contacts. The reverse generated the worst outcomes, likely to disrupt the provision of vital community services. Both measures were proven effective; however, results demonstrated that ‘increasing flu-vaccination rates’ is a more powerful strategy than ‘limiting social contacts’. Results support two affordable preventive measures: (i) to globally increase influenza-vaccination rates, (ii) to limit the number of personal contacts during outbreaks. The authors endorse changing practices and research incentives towards multidisciplinary collaborations. The urgency of the situation is a call for international health policy to promote interdisciplinary modern technologies in public health engineering.
- 27 August 2021
- Published by Oxford University Press (OUP) in Family Practice
- Vol. 38 (Supplement) , i16-i22
Open AccessCOVID-19 and the flu: data simulations and computational modelling to guide public health strategies
Pandemics threaten lives and economies. This article addresses the global threat of the anticipated overlap of COVID-19 with seasonal-influenza. Scientific evidence based on simulation methodology is presented to reveal the impact of a dual outbreak, with scenarios intended for propagation analysis. This article aims at researchers, clinicians of family medicine, general practice and policy-makers worldwide. The implications for the clinical practice of primary health care are discussed. Current research is an effort to explore new directions in epidemiology and health services delivery. Projections consisted of machine learning, dynamic modelling algorithms and whole simulations. Input data consisted of global indicators of infectious diseases. Four simulations were run for ‘20% versus 60% flu-vaccinated populations’ and ‘10 versus 20 personal contacts’. Outputs consisted of numerical values and mathematical graphs. Outputs consisted of numbers for ‘never infected’, ‘vaccinated’, ‘infected/recovered’, ‘symptomatic/asymptomatic’ and ‘deceased’ individuals. Peaks, percentages, R0, durations are reported. The best-case scenario was one with a higher flu-vaccination rate and fewer contacts. The reverse generated the worst outcomes, likely to disrupt the provision of vital community services. Both measures were proven effective; however, results demonstrated that ‘increasing flu-vaccination rates’ is a more powerful strategy than ‘limiting social contacts’. Results support two affordable preventive measures: (i) to globally increase influenza-vaccination rates, (ii) to limit the number of personal contacts during outbreaks. The authors endorse changing practices and research incentives towards multidisciplinary collaborations. The urgency of the situation is a call for international health policy to promote interdisciplinary modern technologies in public health engineering.